Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
07/07/202215:26Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/07/202205:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/07/202205:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/06/202215:34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/06/202207:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/05/202215:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202215:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202215:05GlobeNewswire Inc.Adamis Appoints Vickie Reed to Board of DirectorsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/05/202216:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and GrowthNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/05/202215:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/05/202215:35GlobeNewswire Inc.Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/05/202216:56GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/05/202216:07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202216:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202215:49GlobeNewswire Inc.Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202215:14GlobeNewswire Inc.US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster ModelNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/03/202215:05GlobeNewswire Inc.Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing DefectNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Retirement of Richard C. Williams, Chairman of the BoardNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/02/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals’ Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment ExpectationsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/02/202215:05GlobeNewswire Inc.Adamis Announces Inducement Option Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/02/202216:44Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/02/202208:17GlobeNewswire Inc.Adamis Pharmaceuticals Provides Enrollment Update of Subjects in Phase 2/3 Study of Tempol for the Treatment of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/01/202203:07TipRanksAdamis Pharma Updates 1 Key Risk FactorNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/01/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/12/202106:30GlobeNewswire Inc.Adamis Pharmaceuticals Updates Comparative Pharmacology Model Data Supporting the Higher 5 mg Intramuscular Dose of Naloxone in ZIMHI™NASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/11/202113:39GlobeNewswire Inc.Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing RequirementsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/11/202115:47GlobeNewswire Inc.Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/11/202114:34GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP